Similar articles

• Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen.

  Hinterberger W, Alth G, Höcker P, Kallinger W, Kier P, Kolbabek H, Lechner K, Popov-Kraup T. Hinterberger W, et al. Bone Marrow Transplant. 1991;7 Suppl 2:43. Bone Marrow Transplant. 1991. PMID: 1652329 No abstract available.
• Immune globulin therapy in allogeneic bone marrow transplant: a critical review.

  Guglielmo BJ, Wong-Beringer A, Linker CA. Guglielmo BJ, et al. Bone Marrow Transplant. 1994 May;13(5):499-510. Bone Marrow Transplant. 1994. PMID: 8054903 Review.
• Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. A pilot study.

  Lehn P, Quessar A, Devergie A, Esperou-Bourdeau H, Traineau R, Trédaniel J, Benbunan M, Bussel A, Jolivet I, Mazeron MC, et al. Lehn P, et al. Nouv Rev Fr Hematol (1978). 1990;32(1):17-20. Nouv Rev Fr Hematol (1978). 1990. PMID: 2161510
• Should all CMV infections after bone marrow transplantation be treated?

  Jouet JP, Draoui A, Facon T, Noel-Walter MP, Wattre P, Fenaux P, Dupriez B, Morel P, Bauters F. Jouet JP, et al. Bone Marrow Transplant. 1991;7 Suppl 2:47. Bone Marrow Transplant. 1991. PMID: 1652333 No abstract available.
• [Prevention of cytomegalovirus infection and disease in the transplantation patient].

  Cisneros JM, Pachón J. Cisneros JM, et al. Enferm Infecc Microbiol Clin. 1993 Jan;11(1):40-4. Enferm Infecc Microbiol Clin. 1993. PMID: 8384888 Review. Spanish. No abstract available.